Skip to main content

Find Clinical Trials

Home
Conditions
Waldenström Macroglobulinemia

Clinical trial condition

Waldenström Macroglobulinemia

Explore clinical trials studying Waldenström Macroglobulinemia. Study availability and eligibility vary by location and protocol.

70 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Waldenström Macroglobulinemia trial results

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center - Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 20 locations

View Trial Details

Completed

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

NCT00566332

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Hôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital Paris, France

View Trial Details

Completed

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

NCT01658319

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00003210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +51 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

NCT01158274

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +151 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

NCT00621452

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00110071

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma

NCT00054639

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00290472

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations: University of Chicago Chicago, Illinois, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Evanston Hospital CCOP Evanston, Illinois, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

View all 13 locations

View Trial Details